The total return over the past 12 months is +24.12% vs. +19.98% for the S&P 500. So far it's up +20.19% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +15.94% | (7.34%) | (9.49%) | (1.46%) | +3.29% | +0.36% |
| Total Return CAGR | +24.12% | (1.18%) | (4.55%) | +3.22% | +7.85% | +4.95% |
| Revenue CAGR | (0.21%) | (11.07%) | +6.29% | +2.20% | (0.39%) | +1.12% |
| Net Income CAGR | (59.69%) | (44.41%) | (15.83%) | (5.36%) | (4.29%) | (4.86%) |
| EPS CAGR | (60.05%) | +90.23% | (3.78%) | +1.89% | +1.87% | +1.40% |
| Free Cash Flow CAGR | (11.67%) | +1.00% | (3.11%) | (2.29%) | (4.16%) | (1.00%) |
| Operating Cash Flow CAGR | (11.76%) | (16.40%) | (3.11%) | (1.40%) | (3.33%) | (0.72%) |
| Dividends CAGR | +2.38% | +2.44% | +2.50% | +4.38% | +5.98% | +4.44% |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Pfizer Inc. (PFE)
| Year | Start price | End price | PFE Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $24.90 | $28.45 | +20.19% | +13.55% | +6.64% |
| 2025 | $26.53 | $24.90 | +0.67% | +17.72% | (17.05%) |
| 2024 | $28.79 | $26.53 | (2.24%) | +24.89% | (27.13%) |
| 2023 | $51.24 | $28.79 | (41.22%) | +26.19% | (67.41%) |
| 2022 | $59.05 | $51.24 | (10.42%) | (18.17%) | +7.75% |
| 2021 | $36.81 | $59.05 | +66.74% | +28.74% | +38.00% |
| 2020 | $37.14 | $36.81 | +3.44% | +18.37% | (14.93%) |
| 2019 | $41.38 | $37.14 | (6.74%) | +31.22% | (37.96%) |
| 2018 | $34.33 | $41.38 | +25.08% | (4.56%) | +29.64% |
| 2017 | $30.79 | $34.33 | +16.11% | +21.70% | (5.59%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
